Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
11
0
9
N/A
0
12
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ed Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Worked with same sponsors:
John Magee, MD
University of Michigan Medical Center, Ann Arbor
Shared therapeutic areas:
Worked with same sponsors:
Lisa Henn, PhD
Arbor Research Collaborative of Health
Shared therapeutic areas:
Worked with same sponsors:
Benjamin Shneider, MD
Baylor College of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Valerie L Durkalski-Mauldin, PhD
Medical University of South Carolina
Shared therapeutic areas:
Worked with same sponsors:
Estella M Alonso, MD
Ann & Robert H Lurie Children's Hospital of Chicago
Shared therapeutic areas:
Worked with same sponsors:
Robert M Merion, MD
University of Michigan
Shared therapeutic areas:
Worked with same sponsors:
Daniela Ladner, MD MPH
Northwestern Univesity
Shared therapeutic areas:
Worked with same sponsors:
Donna Woods, PhD
Northwestern University
Shared therapeutic areas:
Worked with same sponsors:
Edward Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
TReatment for ImmUne Mediated PathopHysiology
Longitudinal Assessment of Transient Elastography in Cystic Fibrosis
MRI to Characterize and Predict CF Liver Disease in PUSH Cohort
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Adult-to-Adult Living Donor Transplant Cohort Study
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis
A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy
Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
All 11 trials loaded